Pomalidomide with Dexamethasone for Treating Relapsed and Refractory Multiple Myeloma Previously Treated with Lenalidomide and Bortezomib: An Evidence Review Group Perspective of an NICE Single Technology Appraisal

2017-10-31

Pomalidomide with Dexamethasone for Treating Relapsed and Refractory Multiple Myeloma Previously Treated with Lenalidomide and Bortezomib

An Evidence Review Group Perspective of an NICE Single Technology Appraisal

Additional Metadata
Persistent URL	doi.org/10.1007/s40273-017-0581-6, hdl.handle.net/1765/105114
Journal	PharmacoEconomics
Organisation	Institute for Medical Technology Assessment (iMTA)
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Büyükkaramikli, N., de Groot, S., Fayter, Debra, Wolff, Robert, Armstrong, N., Stirk, Lisa, … Al, M. (2017). Pomalidomide with Dexamethasone for Treating Relapsed and Refractory Multiple Myeloma Previously Treated with Lenalidomide and Bortezomib: An Evidence Review Group Perspective of an NICE Single Technology Appraisal. PharmacoEconomics. doi:10.1007/s40273-017-0581-6